Daniel Joseph, Pradhan Chandra, Ziaee Hena, McMinn Derek J W
The McMinn Centre, 25 Highfield Road, Edgbaston, Birmingham B15 3DP, United Kingdom.
Orthopedics. 2008 Dec;31(12 Suppl 2).
This is a 1.2- to 5.3-year survival and clinicoradiologic study of patients with the Birmingham Mid-Head Resection (BMHR) device (Smith & Nephew Orthopaedics, Warwick, United Kingdom). Sixty consecutive hips implanted with this device between 2003 and 2007 were reviewed with hip outcome questionnaires, clinical examination, and radiographs at a minimum follow-up of 1 year. There were no revisions, mechanical failures, or signs of femoral neck stress shielding. All hips were functioning well and showed no significant adverse clinical or radiographic features. Birmingham Mid-Head Replacement offers the prospect of circumventing the need for a more invasive procedure such as hip replacement in patients who would benefit from a conservative arthroplasty but lack femoral head bone quality, which is a prerequisite for a successful hip resurfacing.
这是一项针对使用伯明翰中头切除(BMHR)装置(英国华威市施乐辉骨科公司)患者的1.2至5.3年生存率及临床放射学研究。对2003年至2007年间连续60例植入该装置的髋关节进行了回顾,通过髋关节预后问卷、临床检查及X线片进行评估,最短随访时间为1年。未出现翻修、机械故障或股骨颈应力遮挡迹象。所有髋关节功能良好,未显示出明显的不良临床或放射学特征。对于那些能从保守性关节成形术中获益但缺乏股骨头骨质(这是成功进行髋关节表面置换的先决条件)的患者,伯明翰中头置换术提供了一种避免进行如髋关节置换等更具侵入性手术的可能性。